Michigan Society of Histotechnologists

06/06/2026

Spring seminar Tomorrow!! Register now and watch anytime over the next 30 days!

VIRTUAL ATTENDEES: Can’t attend in person? Be a virtual attendee! Choose to attend online and live stream from wherever you are! Full details on accessing the webcast along with any associated handouts will be emailed to you after April 25th. Not available...

06/03/2026

Couldn’t have said it better!

Just wrapped up my third state histology symposium of the year: Missouri, Wisconsin, and the joint WI/IL meeting. Three different meetings, one consistent takeaway: these spaces matter. The lectures are extremely valuable. From leadership panels and real-world case reviews to hands-on labs and techn...

05/28/2026

We’re just one week away from our Spring Seminar! Spend the day connecting with exhibitors and fellow professionals. Enjoy a full lineup of presentations from leading experts, a hot breakfast, and a special lunch-and-learn session.
All in-person attendees will be eligible to qualify for exciting door prizes during the event.
Register now at:
https://www.mihisto.org/seminars

05/25/2026

Congratulations Karen Marshall-Sly on winning the Facebook Lottery! We look forward to seeing you at the Spring Seminar!

The MSH Spring Seminar Facebook Lottery has begun! Lottery will close Saturday May 23rd. Winner will be selected May 24th.

The rules are easy:

1. Be a current MSH Member.
2.Find the original Facebook post of the Lottery.
3.Like the post and leave a comment telling us what type of topic you would like to see presented at the next seminar.
4.Share the post on your wall.
5.That's it!

Have you already registered? Not a problem, the MSH will reimburse the winner the registration fee.

Want to register today? Click on the link below:
https://www.mihisto.org/seminars

05/17/2026

The MSH Spring Seminar Facebook Lottery has begun! Lottery will close Saturday May 23rd. Winner will be selected May 24th.

The rules are easy:

1. Be a current MSH Member.
2.Find the original Facebook post of the Lottery.
3.Like the post and leave a comment telling us what type of topic you would like to see presented at the next seminar.
4.Share the post on your wall.
5.That's it!

Have you already registered? Not a problem, the MSH will reimburse the winner the registration fee.

Want to register today? Click on the link below:
https://www.mihisto.org/seminars

05/13/2026

Not a MSH Member?
Join today at
https://www.mihisto.org/pricing-plans/join-today

Already registered for our Spring Seminar?
Not a problem, winner will be reimbursed.

05/11/2026

Tissue is the Issue: No Meat, No Treat

Presented by:
Cristi Rigazio, HT
Sentara Laboratory Services

Meet the Speaker

Cristi Rigazio earned her Bachelor of Science in 2001 and obtained her Histotechnician (HT) certification in 2004 while working in a pre-clinical research setting. She later transitioned to a hospital environment while pursuing graduate studies, earning a Master of Science in Administration in 2008. Following graduation, Cristi was selected to lead the development and opening of a new pathology laboratory for a gastroenterology practice. In 2016, Cristi joined Sentara Laboratory Services as a Clinical Specialist for Anatomic Pathology. She currently serves in a dual role as Operations Manager and Clinical Specialist, providing system-wide leadership for anatomic pathology and histology services across a 12-hospital healthcare system, with a focus on operational excellence, quality, and workforce development.

Presentation Abstract

Broad molecular profiling to assess biomarkers that drive treatment decisions are now recommended by guidelines for numerous solid tumors. Pathologists, oncologists, radiologists, histologists, and molecular biologists are all key stakeholders in ensuring biomarker testing is performed according to the guidelines.
Due to the dearth of tissue available from fine needle aspirates or core needle biopsies, tissue
stewardship is necessary to allocate the available tissue appropriately. The histology team should understand and address pre-analytical variables affecting the quality of biomarker testing results and how tissue quantity plays into that. It is important to understand how preanalytical variables that occur during tissue processing affect different technologies and how to work together across disciplines to optimize tissue quality and utilization to drive biomarker testing.

Register for the Spring Seminar on June 6th
https://www.mihisto.org/seminars

05/03/2026

Time is Running Out! Early Bird discount pricing ends May 6th.
Attend the Spring Seminar in person in Grand Rapids, MI or virtually on June 6th.
Register today
https://www.mihisto.org/seminars

04/29/2026

Advancements in Histology in Diagnostic Molecular Data and the Role of Artificial Intelligence in Modern Medicine

Presented by:
Dr. Nicholas Hoo-Fatt

Meet the Speaker

Dr. Nicholas Hoo-Fatt has been recognized as one of the Top 55 Laboratory Professionals Under 55 and is the recipient of the 2024 NSH Excellence in Whole Slide Imaging Award. Additionally, he was named an ASCP Blue Ribbon Top 5 Finalist. With over 20 years of experience in histology, Dr. Hoo- Fatt is a leader in bioinformatics, digital pathology, and molecular pathology. He has pioneered the use of RT-PCR for biomarker detection in cancer patients, implementing a 24-hour turnaround time (TAT) methodology that enhances diagnostic efficiency. Beyond his contributions to laboratory medicine, Dr. Hoo-Fatt is a passionate educator who fosters curiosity and learning among his students. Committed to giving back to the community, he leverages his expertise to mentor and inspire individuals of all ages to achieve their aspirations.

Presentation Abstract

A discussion on how recent advancements have revolutionized the ability to generate diagnostic molecular data from patient tissue. Combining developments in artificial intelligence (AI) and machine learning (ML), are now at the forefront of precision medicine. The practice of machine learning algorithms have enabled clinicians to analyze and interpret complex biological information. The utilization of AI and ML continue to evolve in understanding disease resistance mechanisms, tumor origination, risk assessment, early diagnosis, patient prognosis estimation, and personalized treatment plans with unprecedented accuracy. This convergence of technology and healthcare underscores the importance of interdisciplinary collaborations. Ensuring that innovations in computational biology translate into tangible benefits for patients treatment outcome.

Register for the Spring Seminar, June 6th,
https://www.mihisto.org/seminars